Lantheus Medical Imaging Commences Consent Solicitation

N. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“Lantheus”) today announced it commenced a consent solicitation (the “Solicitation”) with respect to a proposed amendment to the indenture (the “Indenture”) governing the company’s outstanding 9.750% Senior Notes Due 2017 (the “Notes”) (CUSIP No. 516545 AC4). The proposed amendment would modify the restricted payments covenant to provide for a $150 million restricted payments basket. The proposed amendments would enable Lantheus to undertake an offering of additional notes under the Indenture and use the proceeds to make a distribution to Lantheus’ immediate parent company and indirectly to Lantheus’ ultimate parent company, Lantheus MI Holdings, Inc. (“Holdings”) to allow Holdings to, among other things, repurchase Holdings’ outstanding preferred stock.

Back to news